Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : RNAi -- Ignore unavailable to you. Want to Upgrade?

To: Thomas who wrote (472)	8/15/2006 3:08:31 AM
From: Thomas	Read Replies (1) \| Respond to of 671

This sounds like a pretty promising development, though the concept of attacking the tumor's blood supply makes me a bit nervous. They do make the point, though, that blood vessels feeding tumors are much wider and can thus accommodate the liposome wrapped sirna, whereas normal blood vessels at 2 nm cannot. newswise.com Is this as big a deal as it sounds from reading the article, or are there similar delivery/efficacy results from other animal model trials? Thanks in advance. Cheers, Thomas